Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 2 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 4Other hematologic neoplasm 3Breast 3Classical hematology 2Plasma cell 1Other 1Myeloid 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Breast Neoplasms 22Vitamin D Deficiency 3Osteoporosis 2Obesity 2Carcinoma, Intraductal, Noninfiltrating 2Triple Negative Breast Neoplasms 1Pathologic Processes 1Pain 1Osteoporosis Secondary 1Neuralgia 1Neoplasms by Site 1Neoplasms 1Musculoskeletal Diseases 1Locally Advanced Breast Cancer and Large Operable Breast Cancer 1Hyperplasia 1Breast Diseases 1Breast Carcinoma In Situ 1Biomarker Change Linked to Breast Cancer 1Arthralgia 1

Interventions

Cholecalciferol 3exemestane 1Vitamin D 1Tamoxifen 1Sugars 1Anastrozole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Vitamin D Deficiency × Cholecalciferol × Breast × Clear all
NCT04677816 2026-04-14

Impact of Vitamin D Supplementation on the Rate of Pathologic Complete Response in Vitamin D Deficient Patients

Wake Forest University Health Sciences

Phase 2 Recruiting
50 enrolled
Breast

Vitamin D Deficiency, Triple Negative Breast Neoplasms

NCT03986268 2024-02-22

Vitamin D Can Increase Pathological Response of the Breast Cancer Patients Treated With Neoadjuvant Therapy

Florence Nightingale Hospital, Istanbul

Phase NA Completed
64 enrolled
Breast

Breast Neoplasms, Vitamin D Deficiency

NCT01240213 2013-08-07

ViDA

Fred Hutchinson Cancer Center

Phase NA Completed
218 enrolled
BreastOther

Breast Neoplasms, Obesity, Vitamin D Deficiency

Data powered by HemOnc (CC BY 4.0) Colophon âš¡